Taco Bell Raises Money for LLS

"Austaco Ltd, a franchisee of Taco Bell, is proud to announce this year's fundraising efforts raised a quarter of a million dollars for The Leukemia & Lymphoma Society of Central Texas (LLS). As the Title Sponsor of the LLS Light the Night Walk, Austaco raised funds by selling paper balloons in their Taco Bell locations and through corporate giving.

Taco Bell (Austaco Ltd) celebrated a recent eight week fundraising effort by presenting a check for $250,000 during this year's Light the Night Walk, held at the Mueller Development in Austin, Texas on October 16th. The walk began at 7:30 pm after participants picked up their illuminated balloons: white for survivors, red for supporters and gold in memory of loved ones lost to cancer.

Twenty five hundred walkers joined in the festivities raising nearly $500,000 for the Light the Night Walk; funds will contribute to lifesaving blood cancer research, financial assistance to cover patient expenses, free educational materials and events for patients and their families and local programs geared towards saving the lives of people with blood cancer."

Read the whole story here: http://www.marketwire.com/press-release/Taco-Bell-Austaco-Ltd-Raises-250...

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap